Acorda Asks Fed. Circ. To Undo Nix Of Ampyra Drug Patents
Acorda on Wednesday kicked off its arguments challenging a Delaware federal judge's invalidation of the asserted claims of patents covering its blockbuster multiple sclerosis drug Ampyra, contending that the judge erred...To view the full article, register now.
Already a subscriber? Click here to view full article